Table 1.
Demographic and clinical characteristics of selected patients with pancreatic adenocarcinoma in the head of pancreas who underwent laparoscopic or robotic DP with curative intent between 2010–2020
| N | 1537 | |
|---|---|---|
| Age | Mean ± SD, median | 68.1 ± 10.99, 69 |
| Sex | Male | 740 (48.1%) |
| Female | 797 (51.9%) | |
| Race | White | 1220 (79.4%) |
| Black | 182 (11.8%) | |
| Other | 135 (8.8%) | |
| Charlson score | 0 | 883 (79.4%) |
| 1 | 429 (27.9%) | |
| 2 | 122 (7.9%) | |
| 3 | 103 (6.7%) | |
| T stage | T1 | 319 (20.8%) |
| T2 | 401 (26.1%) | |
| T3 | 817 (53.2%) | |
| Neoadjuvant therapy | Chemotherapy | 298 (19.4%) |
| Radiation | 76 (4.9%) | |
| Facility type | CCC | 15 (1.0%) |
| CCCP | 359 (23.4%) | |
| A/RP | 820 (53.4%) | |
| INCP | 323 (21.0%) | |
| Not reported | 20 (1.3%) | |
| Annual DP center volume | Median [IQR] | 5 [3–11] |
| Annual MIDP center volume | Median [IQR] | 3 [1–5] |
| Area | Metropolitan | 1250 (81.3%) |
| Urban | 183 (11.9%) | |
| Rural | 31 (2.0%) | |
| Not reported | 73 (4.7%) | |
| Approach | Laparoscopic DP | 1144 (74.4%) |
| Robotic DP | 393 (25.6%) | |
| Conversion | No | 1214 (79.0%) |
| Yes | 323 (21.0%) | |
| Margins | Negative | 1327 (86.3%) |
| Positive | 210 (13.7%) | |
| Examined nodes | Mean ± SD, median | 15.4 ± 10.1, 14 |
| Length of stay | Mean ± SD, median | 6.2 ± 4.7, 5 |
| Unplanned 30-day readmission | 119 (7.7%) | |
| Mortality | 30-day | 22 (1.4%) |
| 90-day | 44 (2.9%) | |
| Adjuvant systemic therapy | 874 (56.9%) | |
A/RP Academic/Research Program, CCC Community Cancer Program, CCCP Comprehensive Community Cancer Program, DP Distal Pancreatectomy, INCP Integrated Network Cancer Program, IQR Interquartile Range, SD Standard Deviation